Last reviewed · How we verify
Aclidinium bromide and formoterol
At a glance
| Generic name | Aclidinium bromide and formoterol |
|---|---|
| Sponsor | AstraZeneca |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
- Upper respiratory tract infection
- Headache
- Back pain
- Cough
- Sinusitis
- Influenza
- Tooth abscess
- Insomnia
- Dizziness
- Dry mouth
- Oropharyngeal pain
- Muscle spasms
Serious adverse events
- Asthma-related death
- Paradoxical bronchospasm
- Immediate hypersensitivity reactions
- Cardiovascular effects
- Worsening of narrow-angle glaucoma
- Worsening of urinary retention
Key clinical trials
- Study to Assess Efficacy and Safety of Aclidinium Bromide and Aclidinium Bromide/Formoterol Fumarate in Stabile COPD Patients (PHASE3)
- Aclidinium Bromide Post-Authorisation Safety Study to Evaluate the Risk of Cardiovascular Endpoints
- Inhaled Long-acting Bronchodilators With or Without Inhaled Glucocorticosteroids for Preventing Hospitalizations and Death in Elderly Patients With Chronic Obstructive Pulmonary Disease (PHASE4)
- Microbiome Use to Stratify Use of Inhaled Corticosteroids: MUSIC Trial (PHASE4)
- The Effect of Twice Daily vs. Once Daily Bronchodilation on Hyperinflation in COPD Patients During 24 Hours. (PHASE4)
- Pharmacokinetics, Safety and Tolerability of Twice-Daily Aclidinium Bromide/Formoterol Fumarate Fixed Dose Combination in Chinese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (PHASE2)
- Effect of Aclidinium/Formoterol on Nighttime Lung Function and Morning Symptoms in Chronic Obstructive Pulmonary Disease (PHASE4)
- The Effects of Inhaled Aclidinium Bromide/Formoterol Fumarate on Inspiratory Pleural Pressures in Smokers (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Aclidinium bromide and formoterol CI brief — competitive landscape report
- Aclidinium bromide and formoterol updates RSS · CI watch RSS
- AstraZeneca portfolio CI